Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
30.34
+0.51 (1.71%)
At close: Aug 26, 2025, 4:00 PM
30.69
+0.35 (1.15%)
After-hours: Aug 26, 2025, 6:50 PM EDT
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts that cover Amphastar Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $35.5, which forecasts a 17.01% increase in the stock price over the next year. The lowest target is $25 and the highest is $55.
Price Target: $35.5 (+17.01%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $28 → $32 | Hold | Maintains | $28 → $32 | +5.47% | Aug 26, 2025 |
| Needham | Needham | Hold → Strong Buy Upgrades $36 | Hold → Strong Buy | Upgrades | $36 | +18.66% | Aug 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $30 → $25 | Hold | Maintains | $30 → $25 | -17.60% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $45 → $30 | Buy → Hold | Downgrades | $45 → $30 | -1.12% | May 12, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +15.36% | May 8, 2025 |
Financial Forecast
Revenue This Year
739.72M
from 731.97M
Increased by 1.06%
Revenue Next Year
791.98M
from 739.72M
Increased by 7.06%
EPS This Year
3.41
from 3.06
Increased by 11.49%
EPS Next Year
3.85
from 3.41
Increased by 12.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 787.1M | 929.8M | |||
| Avg | 739.7M | 792.0M | |||
| Low | 695.8M | 722.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.5% | 25.7% | |||
| Avg | 1.1% | 7.1% | |||
| Low | -4.9% | -2.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.75 | 5.05 | |||
| Avg | 3.41 | 3.85 | |||
| Low | 2.97 | 3.22 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.6% | 48.2% | |||
| Avg | 11.5% | 13.0% | |||
| Low | -3.0% | -5.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.